Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome

Prenatal Diagnosis

Volumn 33, Issue 9, 2013, Pages 873-883

  Hui, Lisa ^a,b   Wick, Heather C ^c   Moise, Kenneth J ^d,e   Johnson, Anthony ^d,e   Luks, Francois ^f   Haeri, Sina ^g,h   Johnson, Kirby L ^a,c   Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Tufts University   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e MEMORIAL HERMANN HOSPITAL   (United States)

^f BROWN UNIVERSITY   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE RNA; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FETUS; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MALE; MICROARRAY ANALYSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; TRANSCRIPTOMICS; TWIN TWIN TRANSFUSION SYNDROME; TWINS;

AMNIOTIC FLUID; CASE-CONTROL STUDIES; FEMALE; FETOFETAL TRANSFUSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; PREGNANCY; RNA; TRANSCRIPTOME; TRANSPLANTATION; TWINS;

EID: 84883461467     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4150     Document Type: Article

References (38)

1. Gonsoulin W, Moise KJ, Jr., Kirshon B, et al. Outcome of twin-twin transfusion diagnosed before 28weeks of gestation. Obstet Gynecol 1990;75:214-6.
2. Saunders NJ, Snijders RJ, Nicolaides KH. Therapeutic amniocentesis in twin-twin transfusion syndrome appearing in the second trimester of pregnancy. Am J Obstet Gynecol 1992;166:820-4.
3. Shah DM, Chaffin D. Perinatal outcome in very preterm births with twin-twin transfusion syndrome. Am J Obstet Gynecol 1989;161:1111-3.
4. Fisk NM, Duncombe GJ, Sullivan MHF. The basic and clinical science of twin-twin transfusion syndrome. Placenta 2009;30:379-90.
5. Roberts D, Gates S, Kilby M, Neilson JP. Interventions for twin-twin transfusion syndrome: a Cochrane review. Ultrasound Obstet Gynecol 2008;31:701-11.
6. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004;351:136-44.
7. Salomon LJ, Ortqvist L, Aegerter P, et al. Long-term developmental follow-up of infants who participated in a randomized clinical trial of amniocentesis vs laser photocoagulation for the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2010;203:444 e1-7.
8. Rossi AC, Vanderbilt D, Chmait RH. Neurodevelopmental outcomes after laser therapy for twin-twin transfusion syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011;118:1145-50.
9. Kowitt B, Tucker R, Watson-Smith D, et al. Long-term morbidity after fetal endoscopic surgery for severe twin-to-twin transfusion syndrome. J Pediatr Surg 2012;47:51-6.
10. Lopriore E, van Wezel-Meijler G, Middeldorp JM, et al. Incidence, origin, and character of cerebral injury in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Am J Obstet Gynecol 2006;194:1215-20.
11. Quarello E, Molho M, Ville Y. Incidence, mechanisms, and patterns of fetal cerebral lesions in twin-to-twin transfusion syndrome. J Matern Fetal Neonatal Med 2007;20:589-97.
12. Spruijt M, Steggerda S, Rath M, et al. Cerebral injury in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol 2012;120:15-20.
13. Habli M, Michelfelder E, Cnota J, et al. Prevalence and progression of recipient-twin cardiomyopathy in early-stage twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2012;39:63-8.
14. Stirnemann JJ, Mougeot M, Proulx F, et al. Profiling fetal cardiac function in twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2010;35:19-27.
15. Lopriore E, Bokenkamp R, Rijlaarsdam M, et al. Congenital heart disease in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Congenit Heart Dis 2007;2:38-43.
16. Herberg U, Gross W, Bartmann P, et al. Long term cardiac follow up of severe twin to twin transfusion syndrome after intrauterine laser coagulation. Heart 2006;92:95-100.
17. Halvorsen CP, Bilock SL, Pilo C, et al. Childhood cardiac function after twin-to-twin transfusion syndrome - a 10-year follow up. Acta Paediatr 2009;98:1468-74.
18. Bajoria R, Ward S, Chatterjee R. Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome. Am J Obstet Gynecol 2002;186:121-7.
19. Mahieu-Caputo D, Dommergues M, Delezoide AL, et al. Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am J Pathol 2000;156:629-36.
20. Bajoria R, Sullivan M, Fisk NM. Endothelin concentrations in monochorionic twins with severe twin-twin transfusion syndrome. Hum Reprod 1999;14:1614-8.
21. Habli M, Cnota J, Michelfelder E, et al. The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome. Am J Obstet Gynecol 2010;203:404 e1-7.
22. Van Mieghem T, Done E, Gucciardo L, et al. Amniotic fluid markers of fetal cardiac dysfunction in twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2010;202:48 e1-7.
23. Fox CE, Lash GE, Pretlove SJ, et al. Maternal plasma and amniotic fluid angiogenic factors and their receptors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 2010;35:695-701.
24. Hui L, Slonim DK, Wick HC, et al. The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol 2012;119:111-8.
25. Larrabee PB, Johnson KL, Lai C, et al. Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA 2005;293:836-42.
26. Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfusion syndrome. J Perinatol 1999;19:550-5.
27. Dietz JA, Johnson KL, Massingham LJ, et al. Comparison of extraction techniques for amniotic fluid supernatant demonstrates improved yield of cell-free fetal RNA. Prenat Diagn 2011;31:598-9.
28. Gentleman R. Reproducible research: a bioinformatics case study. Stat Appl Genet Mol Biol 2005;4: Article2.
29. Ramanan VK, Shen L, Moore JH, Saykin AJ. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet 2012;28:323-32.
30. Pavlidis P, Noble WS Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003;19:295-296.
31. Tessarollo L, Tsoulfas P, Donovan MJ, et al. Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proc Natl Acad Sci USA 1997;94:14, 776-81.
32. Bajoria R, Ward S, Sooranna SR. Influence of vasopressin in the pathogenesis of oligohydramnios-polyhydramnios in monochorionic twins. Eur J Obstet Gynecol Reprod Biol 2004;113:49-55.
33. Li X, Chan TO, Myers V, et al. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Galphaq-mediated cell signaling. Circulation 2011;124:572-81.
34. Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005;65:73-82.
35. Arai Y, Fujimori A, Sudoh K, Sasamata M. Vasopressin receptor antagonists: potential indications and clinical results. Curr Opin Pharmacol 2007;7:124-9.
36. Valania G, Singh M, Slawsky MT. Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? Curr Heart Fail Rep 2011;8:198-205.
37. Thibonnier M Vasopressin receptor antagonists in heart failure. Curr Opin Pharmacol 2003;3:683-7.
38. Bianchi DW. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nat Med 2012;18:1041-51.